arrow
Y

Yibo Wu

zhe jiang university
H指数:8
被引数:224

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study

亚洲成人HSCT受者TA-TMA风险分层和新预后生物标志物的验证:一项多中心真实世界研究

2026-01-090
PRE
NUP98 rearrangement dynamics predict outcomes in adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multicenter real-world study

NUP98重排动力学可预测接受allo-HSCT治疗的急性髓系白血病成年患者结局:一项多中心真实世界研究

2025-08-050
PRE
Higher risk of platelet engraftment failure and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T-cell therapy compared to chemotherapy: A propensity score-matched analysis

与化疗相比,嵌合抗原受体T细胞疗法后进行异基因造血干细胞移植,血小板植入失败和慢性移植物抗宿主病的风险更高:一项倾向性评分匹配分析

2025-06-040
PRE
Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual disease
2025-01-230
OAAI
Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: a retrospective analysis
2024-07-041
PRE
Impact of Donor-to-Recipient ABO Mismatch on Outcomes of Antithymocyte Globulin-Based Peripheral Blood Stem Cell-Derived Myeloablative Conditioning Haploidentical Stem Cell Transplantation

供受体ABO不匹配对基于抗胸腺细胞球蛋白的外周血干细胞来源的清髓性预处理单倍体干细胞移植结局的影响

2022-06-013
OAAI